Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
about
Discoidin Domain Receptors: Potential Actors and Targets in CancerDiscoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discoveryA membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cellsStructural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase InhibitorsKRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapySystematic Quality Control Analysis of LINCS DataDiscoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.Discoidin domain receptors in disease.Discoidin domain receptor functions in physiological and pathological conditions.Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal diseaseStructure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.Glycosylation at Asn211 regulates the activation state of the discoidin domain receptor 1 (DDR1).Discoidin domain receptors: a proteomic portrait.Discoidin domain receptor 2 signaling networks and therapy in lung cancer.DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studies.Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.The study of homology between tumor progression genes and members of retroviridae as a tool to predict target-directed therapy failure.Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458.Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity.Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening.
P2860
Q26751157-04FD5057-5C7D-4215-BA47-113AD0153265Q26853215-C416EC93-F5CA-4952-990F-3959D9FCC61CQ27318442-B622A981-BBE6-40B7-B979-E7ABCF87495DQ27683558-43EAE756-0D9E-4181-BAEC-CA6166460F91Q28069764-263A8807-0485-4976-83FC-DE9F13435E18Q28818488-4D2A1128-8C4C-42B4-8080-12E145C51444Q33586567-9D792644-88F3-44E5-A0B6-7D50DD3131F7Q33605357-4B5BF145-9D93-4CDE-8BC7-5704077989B0Q33611605-D5770BAD-2177-4B83-9077-6370F131567DQ36140733-4018CE4F-6C49-4F48-A778-EBCAFB774765Q36583215-034A049E-ECB7-41A8-A677-CA25BF03B4EEQ37317054-31E3CEB6-795F-4DE3-BEA3-CD1D238CA00EQ37691663-49D2CA4F-B975-4987-BD34-B9E09134680BQ38202550-629A3B05-488B-4906-A923-8654E52F05DAQ38211796-CA8053AC-33DE-4F67-A008-93E62ED5A89DQ38737103-C25FFA60-65DF-4205-AB4A-E22C14ABE8F4Q38740434-6777CC24-248F-4C6D-BE05-985A0D8F172FQ38748552-59023241-6B10-405E-8A31-5E64B8B51C50Q38895436-F30FB341-8413-4313-AD28-1222271709D3Q39042485-AD779DF0-A817-403B-BEAE-F5963A2C69DCQ39411956-CB34230E-D826-47FD-86CF-F03DD7D639B2Q40151542-F2A98344-22FE-4725-9731-2F7E6FE7D9CDQ40830443-690D2696-623A-4948-81C6-AEFE53419517Q41108643-4D5E2905-53DB-43B5-BFCC-1BAF98A9E151Q42934552-6B9EF77F-D68E-4F94-AEDC-D31D0AF15692Q46173337-0C315D41-68E5-4F3C-B71F-5AE05252E0DCQ47940225-0746197E-5F6B-4AF9-A90D-F02D37688E5DQ48021722-58A33E33-483D-474E-99A5-FE677DDF2866Q55026945-7CA38F08-D83E-464C-B02E-18F56458EAEC
P2860
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@ast
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@en
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@nl
type
label
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@ast
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@en
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@nl
prefLabel
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@ast
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@en
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
@nl
P2093
P2860
P3181
P356
P1433
P1476
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor
@en
P2093
Alex N Bullock
Anna Mandinova
Ellen L Weisberg
Feiyang Liu
Hwan Geun Choi
Hyung-Gu Kim
James D Griffin
Jinhua Wang
P2860
P304
P3181
P356
10.1021/CB400430T
P577
2013-08-13T00:00:00Z